How Big Will the SpaceX IPO Be?
Operated up to now as a private business, SpaceX will…
Sell
39
USAQ Quote, Financials, Valuation and Earnings
Last price:
$0.6700
Seasonality move
:
10.4%
Day range:
$0.6700 - $0.6700
52-week range:
$0.0800 - $1.1361
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.37x
P/B ratio:
--
Volume:
1.3K
Avg. volume:
13.6K
1-year change:
207.62%
Market cap:
$7.6M
Revenue:
$2.1M
EPS (TTM):
-$0.04
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, QHSLab, Inc. has -- downside to fair value with a price target of -- per share.
USAQ vs. S&P 500
-
Over the past 5 trading days, QHSLab, Inc. has underperformed the S&P 500 by -3.33% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
QHSLab, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
QHSLab, Inc. has grown year-over-year revenues for 10 quarters straight. In the most recent quarter QHSLab, Inc. reported revenues of $737.1K.
Earnings Growth
-
QHSLab, Inc. earnings have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter QHSLab, Inc. reported earnings per share of $0.00.
Enterprise value:
9M
EV / Invested capital:
--
Price / LTM sales:
3.37x
EV / EBIT:
53.21x
EV / Revenue:
3.44x
PEG ratio (5yr expected):
-0.05x
EV / Free cash flow:
66.48x
Price / Operating cash flow:
65.22x
Enterprise value / EBITDA:
32.29x
Gross Profit (TTM):
$1.7M
Return On Assets:
-22.29%
Net Income Margin (TTM):
-14.8%
Return On Equity:
--
Return On Invested Capital:
-35.74%
Operating Margin:
13.07%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $1.4M | $1.8M | $2.6M | $544.3K | $737.1K | |
| Gross Profit | $666.6K | $1.1M | $1.7M | $347.1K | $475.6K | |
| Operating Income | -$337.4K | $84.2K | $168.8K | $89.1K | $96.3K | |
| EBITDA | -$190.9K | $230.8K | $278.2K | $125.7K | $114.3K | |
| Diluted EPS | -$0.06 | -$0.01 | -$0.04 | $0.00 | $0.00 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $720.2K | $443.3K | $177K | $349.3K | $428.6K | |
| Total Assets | $2.5M | $2.2M | $1.7M | $1.8M | $1.7M | |
| Current Liabilities | $879.3K | $1.7M | $2M | $2.1M | $2.3M | |
| Total Liabilities | $1.9M | $1.9M | $2M | $2.1M | $2.3M | |
| Total Equity | $584.5K | $286.2K | -$299.5K | -$335.3K | -$610.9K | |
| Total Debt | $1.6M | $1.6M | $1.7M | $1.7M | $1.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$94.3K | -$47.8K | $135.1K | -$56.6K | $2.6K | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -$93.4K | $93.5K | -$72.7K | $48.3K | -$12.6K | |
| Free Cash Flow | -$94.2K | -$47.8K | $135.1K | -$56.6K | $2.6K | |
USAQ
Sector
Market Cap
$7.6M
--
Price % of 52-Week High
58.97%
--
Dividend Yield
0%
--
Shareholder Yield
0.81%
--
1-Year Price Total Return
207.62%
--
Beta (5-Year)
0.510
--
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.7400
200-day SMA
Buy
Level
$0.2854
Bollinger Bands (100)
Buy
Level
0.1197 - 0.6197
Chaikin Money Flow
Sell
Level
-12.7K
20-day SMA
Sell
Level
$0.7815
Relative Strength Index (RSI14)
Sell
Level
47.1809
ADX Line
Sell
Level
16.8029
Williams %R
Buy
Level
-100
50-day SMA
Buy
Level
$0.5633
MACD (12, 26)
Buy
Level
0.1927
25-day Aroon Oscillator
Buy
Level
4
On Balance Volume
Sell
Level
-16.2K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-2.4642)
Sell
CA Score
(Annual)
Level (-3.0438)
Buy
Beneish M-Score
(Annual)
Level (-2.4373)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (11.1568)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
QHSLab, Inc. operates as a medical device technology and software as a service company. It focuses on enabling primary care physicians to increase their revenues by providing them with relevant, value-based tools to evaluate, and treat chronic disease through reimbursable procedures. Its products will enable physicians to diagnose and treat patients with chronic diseases which they historically have referred to specialists. The company was founded on September 1, 1983 and is headquartered in West Palm Beach, FL.
Stock Forecast FAQ
In the current month, USAQ has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The USAQ average analyst price target in the past 3 months is --.
-
Where Will QHSLab, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that QHSLab, Inc. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About QHSLab, Inc.?
Analysts are divided on their view about QHSLab, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that QHSLab, Inc. is a Sell and believe this share price will rise from its current level to --.
-
What Is QHSLab, Inc.'s Price Target?
The price target for QHSLab, Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is USAQ A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for QHSLab, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of USAQ?
You can purchase shares of QHSLab, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase QHSLab, Inc. shares.
-
What Is The QHSLab, Inc. Share Price Today?
QHSLab, Inc. was last trading at $0.6700 per share. This represents the most recent stock quote for QHSLab, Inc.. Yesterday, QHSLab, Inc. closed at $0.6700 per share.
-
How To Buy QHSLab, Inc. Stock Online?
In order to purchase QHSLab, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get USAQ Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
USAQ
Sector
P/E ratio
--
--
PEG ratio
-0.05x
--
P/B ratio
--
--
Price / LTM sales
3.37x
--
Growth Metrics
USAQ
Sector
Revenue growth
35.42%
--
Earnings growth
-37.04%
--
Revenue (5-year growth)
--
--
Earnings forecast
--
--
Profitability
USAQ
Sector
Profitability FY 2024
$1.3M
--
Return on invested capital
-35.74%
--
Return on assets
-22.29%
--
Return on equity
--
--
Earnings Date
Last Earnings Date
Feb
8
Next Earnings Date
Feb
8
Estimated Next Earnings Date
May
10
Balance Sheet
USAQ
Sector
Total cash
$158.4K
--
Short term investments
--
--
Total assets
$1.8M
--
Long term debt
$1.6M
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will ISRG Stock Be in 5 Years?
Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…
Is Kratos Stock a Good Investment?
UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
53
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 30x
Alerts
Sell
40
BILL alert for Feb 7
Bill Holdings, Inc. [BILL] is up 37.11% over the past day.
Buy
75
PRLB alert for Feb 7
Proto Labs, Inc. [PRLB] is up 28.33% over the past day.
Sell
30
MSTR alert for Feb 7
Strategy, Inc. [MSTR] is up 26.08% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
